CDC 4370/ Bangkok TFV Study

Phase:III, II
Principal Investigator(s):Kachit Choopanya, MD
Objective:To assess the safety and efficacy of daily tenofovir to prevent parenteral HIV infection among injection drug users (IDU) in Thailand. IDU was defined as individuals who reported substance use in the past year from the time they were screened.Key results: There was a 49% reduction in HIV infection rate among IDU in Thailand with Daily oral TDF. Last update August 10, 2022